• Exchange: GreTai Sec M
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharmaceuticals

Synmosa Biopharma Corp

+ Add to Watchlist

4114:TT

39.25 TWD 0.15 0.38%

As of 02:32:18 ET on 04/16/2014.

Snapshot for Synmosa Biopharma Corp (4114)

Open: 39.20 Day's Range: 39.10 - 39.45 Volume: 338,926
Previous Close: 39.10 52wk Range: 32.24 - 47.90 1-Yr Rtn: +10.98%

Stock Chart for 4114

No chart data available.
  • 4114:TT 39.25
  • 1D
  • 1M
  • 1Y
39.10
Interactive 4114 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4114

Current P/E Ratio (ttm) 38.9133
Estimated P/E(12/2014) 16.3883
Relative P/E vs. TWOTCI 1.1101
Earnings Per Share (TWD) (ttm) 1.0087
Est. EPS (TWD) (12/2014) 2.3950
Est. PEG Ratio -
Market Cap (M TWD) 4,279.70
Shares Outstanding (M) 109.04
30 Day Average Volume 768,129
Price/Book (mrq) 3.1004
Price/Sale (ttm) 3.5924
Dividend Indicated Gross Yield 0.51%
Cash Dividend (TWD) 0.2019
Dividend Ex-Date
5 Year Dividend Growth 4.85%
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4114

No data available

Company Profile & Key Executives for 4114

Synmosa Biopharma Corporation produces prescription and OTC (Over The Counter) medicine, as well as a variety of healthcare products. The Company also distributes pharmaceutical products from Aventis and Orion.

Lin Chih-HuiChairman/PresidentPai Hung-ChinChief Financial Officer
Kuo Chung-ShuDivisional Vice PresidentChiu Chin-TsanDivisional Vice President
More Company Profile & Key Executives for 4114

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil